Kestra Advisory Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$150K	Buy	15,740 +2,680	+21%	+$20.8K	﹤0.01%	2987
2025 Q4	$102K	Sell	13,060 -72	-0.5%	-$521	﹤0.01%	3407
2025 Q3	$99.7K	Buy	13,132 +432	+3%	+$3.6K	﹤0.01%	2820
2025 Q2	$114K	Sell	12,700 -15	-0.1%	-$140	﹤0.01%	2726
2025 Q1	$95.4K	Sell	12,715 -100	-0.8%	-$807	﹤0.01%	2595
2024 Q4	$96.4K	Buy	+12,815	New	+$97.3K	﹤0.01%	2574
2023 Q4	–	Sell	-18,779	Closed	-$133K	–	2274
2023 Q3	$133K	Sell	18,779 -7,300	-28%	-$52.5K	﹤0.01%	1990
2023 Q2	$184K	Buy	26,079 +2,150	+9%	+$17.3K	﹤0.01%	1918
2023 Q1	$200K	Buy	23,929 +2,395	+11%	+$23.1K	﹤0.01%	1843
2022 Q4	$247K	Buy	21,534 +7,220	+50%	+$90K	﹤0.01%	1876
2022 Q3	$180K	Buy	+14,314	New	+$184K	﹤0.01%	1899